Marina Moreira de Castro1, Ligiana Pires Corona2, Lívia Bitencourt Pascoal3, Bruno Lima Rodrigues4, Maria de Lourdes Setsuko Ayrizono5, Claudio Saddy Rodrigues Coy6, Raquel Franco Leal7, Marciane Milanski8. 1. School of Applied Sciences, University of Campinas, UNICAMP, Limeira, Brazil; School of Medical Sciences, University of Campinas (UNICAMP), Medical School, Campinas, São Paulo, Brazil. Electronic address: mah.moreira07@gmail.com. 2. School of Applied Sciences, University of Campinas, UNICAMP, Limeira, Brazil; School of Medical Sciences, University of Campinas (UNICAMP), Medical School, Campinas, São Paulo, Brazil. Electronic address: ligiana.corona@fca.unicamp.br. 3. School of Medical Sciences, University of Campinas (UNICAMP), Medical School, Campinas, São Paulo, Brazil; Obesity and Comorbidities Research Center, University of Campinas, UNICAMP, Campinas, Brazil. Electronic address: liviabitencourt@yahoo.com.br. 4. School of Medical Sciences, University of Campinas (UNICAMP), Medical School, Campinas, São Paulo, Brazil. Electronic address: brunolr.unicamp@gmail.com. 5. School of Medical Sciences, University of Campinas (UNICAMP), Medical School, Campinas, São Paulo, Brazil. Electronic address: luayrizono@terra.com.br. 6. School of Medical Sciences, University of Campinas (UNICAMP), Medical School, Campinas, São Paulo, Brazil. Electronic address: claudiocoy@gmail.com. 7. School of Medical Sciences, University of Campinas (UNICAMP), Medical School, Campinas, São Paulo, Brazil; Obesity and Comorbidities Research Center, University of Campinas, UNICAMP, Campinas, Brazil. Electronic address: rafranco.unicamp@gmail.com. 8. School of Applied Sciences, University of Campinas, UNICAMP, Limeira, Brazil; School of Medical Sciences, University of Campinas (UNICAMP), Medical School, Campinas, São Paulo, Brazil; Obesity and Comorbidities Research Center, University of Campinas, UNICAMP, Campinas, Brazil. Electronic address: marciane.milanski@fca.unicamp.br.
Abstract
BACKGROUND AND AIMS: Crohn's disease is a chronic inflammatory disease consisting of alternated periods of relapse and remission. The disease is associated with altered body composition and micronutrient deficiencies. This study aimed to evaluate the nutritional status of Crohn's disease outpatients in remission and activity of the disease. METHODS: Patients were classified according to Crohn's Disease Endoscopic Index of Severity or Magnetic Resonance Imaging scan. Anthropometric and biochemical analysis was performed for nutritional status evaluation. RESULTS: A total of 60 patients were evaluated of which 31 were in endoscopic remission (mean Crohn's Disease Endoscopic Index of Severity: 1.76) and 29 in activity (mean Crohn's Disease Endoscopic Index of Severity: 7.88). Regarding markers of fat and lean mass, lower values were observed in the activity group when compared to the remission group (p < 0.05). There was a positive correlation regarding the duration of the disease and the anthropometric parameters in patients with active disease. Interestingly, the prevalence of overweight/obese patients was 55% in remission group and 28% in activity group according to the Body Mass Index classification. In addition, lower levels of iron, folic acid and albumin were also observed in Crohn's disease activity group. CONCLUSIONS: We observed important differences in nutritional markers between patients in remission and activity phases, with higher prevalence of overweight/obese in patients with remission of the disease.
BACKGROUND AND AIMS: Crohn's disease is a chronic inflammatory disease consisting of alternated periods of relapse and remission. The disease is associated with altered body composition and micronutrient deficiencies. This study aimed to evaluate the nutritional status of Crohn's disease outpatients in remission and activity of the disease. METHODS:Patients were classified according to Crohn's Disease Endoscopic Index of Severity or Magnetic Resonance Imaging scan. Anthropometric and biochemical analysis was performed for nutritional status evaluation. RESULTS: A total of 60 patients were evaluated of which 31 were in endoscopic remission (mean Crohn's Disease Endoscopic Index of Severity: 1.76) and 29 in activity (mean Crohn's Disease Endoscopic Index of Severity: 7.88). Regarding markers of fat and lean mass, lower values were observed in the activity group when compared to the remission group (p < 0.05). There was a positive correlation regarding the duration of the disease and the anthropometric parameters in patients with active disease. Interestingly, the prevalence of overweight/obesepatients was 55% in remission group and 28% in activity group according to the Body Mass Index classification. In addition, lower levels of iron, folic acid and albumin were also observed in Crohn's disease activity group. CONCLUSIONS: We observed important differences in nutritional markers between patients in remission and activity phases, with higher prevalence of overweight/obese in patients with remission of the disease.